Equibles does not estimate personal net worth.
Get an email with a short summary when Rockwell Medical, Inc. publishes a filing, an earnings call transcript or a press release.
Get RMTI alertsJesse Neary is recorded as CFO at Rockwell Medical, Inc. (RMTI). Jesse Neary has spoken on 6 earnings calls across 1 company, most recently for Rockwell Medical, Inc. on August 13, 2026. Rockwell Medical, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Rockwell Medical, Inc. includes Mark Strobeck (CEO and Board Member), Mark Strobeck, Ph.D. (CEO and Board Member), Russell Ellison (CEO and Board Member) and 7 others.
“Net sales for the three months ended June 30th, 2026, were $17.8 million, representing an 11% increase compared to net sales of $16.1 million for the same period in 2025.”
“Yeah, so Ram, In terms of our longer term projections, we are assuming consistent volumes purchased from DeVita over the next few years. So consistent with essentially what they purchased the last three quarters of last year and going forward into this year.”
“I will now review our second quarter 2025 financial results in greater detail. Net sales for the second quarter were $16.1 million, representing a 38% decrease over net sales of $25.8 million for the same period in 2024.”
“I will now review our first quarter 2025 financial results in greater detail. Net sales for the first quarter were $18.9 million representing a 17% decrease over net sales of $22.7 million for the same period in 2024.”
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
